recombinant human soluble FcgammaR1a (ZymoGenetics)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namerecombinant human soluble FcgammaR1a (ZymoGenetics)
Drug Alias NameCD64A (ZymoGenetics)rh-FcgammaR1a (ZymoGenetics)CD64Arh-FcgammaR1a
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHigh affinity immunoglobulin gamma Fc receptor I agonists
TargetsHigh affinity immunoglobulin gamma Fc receptor I
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZymogenetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZymogenetics Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A